Corrigendum: Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

Corrigendum: Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

Bibliographic Details
Main Authors:	Ema Mosleh, Stacy Snyder, Ningying Wu, Daniel N. Willis, Rema Malone, Robert J. Hayashi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Oncology
Subjects:	methotrexate HDMTX supportive care delayed clearance nephrotoxicity adverse effect
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1333273/full

Similar Items

Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients
by: Ema Mosleh, et al.
Published: (2023-10-01)

A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK
by: Stefan Bielack, et al.
Published: (2024-01-01)

Impact of Methotrexate and 7‐Hydroxymethotrexate Exposure on Renal Toxicity in Pediatric Non‐Hodgkin Lymphoma
by: Hao Bing, et al.
Published: (2025-01-01)

Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib
by: Inge M. van der Sluis, et al.
Published: (2023-12-01)

Methotrexate induced nephrotoxicity: possible underlying mechanisms and promising natural protective agents in experimental models
by: Asmaa M. Algendy, et al.
Published: (2023-12-01)

Formononetin Upregulates Nrf2/HO-1 Signaling and Prevents Oxidative Stress, Inflammation, and Kidney Injury in Methotrexate-Induced Rats
by: Saleem H. Aladaileh, et al.
Published: (2019-09-01)

Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing
by: Zhongbo Hu, et al.
Published: (2024-11-01)

Effects of different concentrations of aqueous green tea extract against methotrexate-induced nephrotoxicity in rats
by: Dawser K. Ismael, et al.
Published: (2011-06-01)

Novel genomic variants influencing methotrexate delayed clearance in pediatric patients with acute lymphoblastic leukemia
by: Jung Yoon Choi, et al.
Published: (2024-11-01)

Platelet Rich Plasma and Adipose-Derived Mesenchymal Stem Cells Mitigate Methotrexate-Induced Nephrotoxicity in Rat via Nrf2/Pparγ/HO-1 and NF-Κb/Keap1/Caspase-3 Signaling Pathways: Oxidative Stress and Apoptosis Interplay
by: Farooq A. Wani, et al.
Published: (2023-04-01)

A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment
by: Stefan S. Bielack, et al.
Published: (2024-10-01)

Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases
by: Nicolò Peccatori, et al.
Published: (2025-06-01)

Outpatient administration of high-dose methotrexate in adults without drug monitoring – a case-control study of risk factors for acute kidney injury
by: Camila Alves, et al.
Published: (2024-12-01)

Nephrotoxicity Development of a Clinical Decision Support System Based on Tree-Based Machine Learning Methods to Detect Diagnostic Biomarkers from Genomic Data in Methotrexate-Induced Rats
by: Ipek Balikci Cicek, et al.
Published: (2023-08-01)

Adverse Oral Reactions Associated with Low Doses of Methotrexate
by: N. V. Izmozherova, et al.
Published: (2020-12-01)

Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice
by: Faizan Mazhar, et al.
Published: (2023-12-01)

Safety Profile Of Methotrexate And Leflunomide In Rheumatoid Arthritis
by: Fuad Shaikh, et al.
Published: (2015-03-01)

Relationship between the efficacy and adverse effects of methotrexate and gene polymorphism
by: Xin Zhao, et al.
Published: (2024-08-01)

Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis
by: Francisco C. Ceballos, et al.
Published: (2023-06-01)

The reaction of the skin and its appendages in rheumatoid arthritis patients using subcutaneous methotrexate: A description of three cases
by: Yu. V. Muravyev, et al.
Published: (2016-10-01)

Genetic polymorphisms as predictors of methotrexate toxicity: literature review
by: G. A. Radzhabova, et al.
Published: (2024-04-01)

SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)

Cutaneous manifestations of systemic methotrexate toxicity
by: Shivani Jain, MPhil, MSc, et al.
Published: (2024-06-01)

Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2022-12-01)

Influence of <i>ABCB1</i> <i>3435C>T</i> polymorphism on methotrexate safety in patients with psoriasis
by: Alexey A. Kubanov, et al.
Published: (2023-02-01)

Distal Tibial Hemimelia in Fetal Methotrexate Syndrome: A Case Study and Literature Review
by: Dae-Sik Jo, et al.
Published: (2023-01-01)

The Effect of Methotrexate 1% Topical Gel on Psoriasis
by: Gita Faghihi, et al.
Published: (2012-03-01)

Delayed Viral Clearance of Chronic Hepatitis C in Patients after Treatment Failure
Published: (2011-03-01)

Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis
by: Chang Jian, et al.
Published: (2023-08-01)

Anticancer Induced Nephrotoxicity: A Review
by: Akram Hammo, et al.
Published: (2022-07-01)

A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
by: Divyanshu Srivastava, et al.
Published: (2023-01-01)

Duration of effect in treatment of methotrexate intolerance in juvenile idiopathic arthritis using Eye Movement Desensitization and Reprocessing (EMDR) can be improved by Bi-lateral Alternating Stimulation Tactile (BLAST) wristbands
by: Lea Höfel, et al.
Published: (2024-10-01)

<i>ABCC1</i>, <i>ABCG2</i> and <i>FOXP3</i>: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis
by: Cristina Membrive-Jiménez, et al.
Published: (2023-09-01)

Methotrexate in the Treatment of Recalcitrant Nodular Vasculitis
by: Sudip Parajuli, et al.
Published: (2015-12-01)

Side Effects of Methotrexate for Psoriasis Therapy
by: Melida Agustina, et al.
Published: (2020-07-01)

Enhancing ovarian cancer treatment: Synergistic effects of methotrexate (Methotrexate)- and quercetin-loaded chitosan nanoparticles
by: Hamed Dadashi, et al.
Published: (2024-12-01)

Misinterpretation of Prescription Leading to Acute Methotrexate Toxicity: An avoidable Accident
by: Farhana Quyum, et al.
Published: (2025-02-01)

4-WEEK OPEN-LABEL CONTROLLED RANDOMIZED COMPARATIVE STUDY OF THE INJECTABLE AND TABLETTED FORMULATIONS OF METHOTREXATE IN RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2011-06-01)

Effect of high saturated free fatty acids feeding on progression of renal failure in rat model of experimental nephrotoxicity
by: Zaid O. Ibraheem, et al.
Published: (2012-02-01)

METHOTREXATE IN THE TREATMENT OF COXITIS IN EARLY SPONDYLOARTHRITIS: ARE THERE PROSPECTS?
by: T. V. Dubinina, et al.
Published: (2015-09-01)